Related Experiment Videos
Thrombotic microangiopathy associated with tuberculous infection
Shoichi Masumoto1, Manami Tada, Ai Katsuma
1Department of Nephrology, National Center for Global Health and Medicine, Japan.
Internal Medicine (Tokyo, Japan)
|September 2, 2011
Summary
A patient with thrombotic microangiopathy (TMA) was successfully treated with plasma exchange (PE). Tuberculosis infection was identified as the likely cause of TMA, highlighting a rare but important association.
Area of Science:
- Nephrology
- Infectious Diseases
- Hematology
Background:
- Thrombotic microangiopathy (TMA) is a rare condition characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ damage.
- Tuberculosis is a global infectious disease that can affect multiple organ systems.
Observation:
- A 32-year-old male presented with symptoms of TMA and was treated with plasma exchange (PE).
- During his hospital stay, the patient was diagnosed with pulmonary tuberculosis, tuberculous peritonitis, and pleuritis.
- The tuberculous infection was considered the underlying cause of the TMA in this patient.
Findings:
- This case report adds to the limited literature on TMA associated with tuberculous infections.
- The pathogenetic mechanisms linking tuberculosis and TMA require further investigation.
- Recognition of this association is crucial for diagnosing and managing TMA in patients with tuberculosis.
Implications:
- Healthcare providers should consider tuberculosis as a potential cause of TMA, especially in endemic areas.
- Early diagnosis and treatment of tuberculosis may help prevent or manage TMA.
- Further research into the pathophysiology of tuberculosis-associated TMA is warranted.
Related Concept Videos
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...